Word

HEMTIVTI

Status

Pending

Status Code

731

Status Date

Wednesday, October 4, 2023

Serial Number

90863206

Mark Type

4000

Filing Date

Tuesday, August 3, 2021

Published for Opposition

Tuesday, May 31, 2022

Trademark Owner History

Pfizer Inc. - Owner At Publication

Classifications

5 Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; pharmaceutical preparations for the treatment of hemophilia

Trademark Events

Oct 6, 2023

Notice Of Approval Of Extension Request E-Mailed

Oct 4, 2023

Sou Extension 2 Granted

Oct 4, 2023

Sou Extension 2 Filed

Oct 4, 2023

Sou Teas Extension Received

May 2, 2023

Notice Of Approval Of Extension Request E-Mailed

Apr 28, 2023

Sou Extension 1 Granted

Apr 28, 2023

Sou Extension 1 Filed

Apr 28, 2023

Sou Teas Extension Received

Apr 6, 2023

Applicant/Correspondence Changes (Non-Responsive) Entered

Apr 6, 2023

Teas Change Of Correspondence Received

Apr 6, 2023

Attorney/Dom.Rep.Revoked And/Or Appointed

Apr 6, 2023

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Apr 6, 2023

Teas Change Of Owner Address Received

Nov 29, 2022

Noa E-Mailed - Sou Required From Applicant

Oct 17, 2022

New Noa To Issue

Jul 26, 2022

Notice Of Allowance Cancelled

Jul 28, 2022

Noa E-Mailed - Sou Required From Applicant

May 31, 2022

Official Gazette Publication Confirmation E-Mailed

May 31, 2022

Published For Opposition

May 11, 2022

Notification Of Notice Of Publication E-Mailed

Apr 27, 2022

Approved For Pub - Principal Register

Apr 26, 2022

Assigned To Examiner

Sep 29, 2021

New Application Office Supplied Data Entered

Aug 6, 2021

New Application Entered